YN968D1

· Elevar Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YN968D1, covering 2017-10-02 to 2017-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalation and Safety Trial of YN968D1 [Phase 1, Phase 2]